Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study

Published:2021-01-22 Issue:3 Volume:10 Page:914-922
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Haruna Yoshimichi¹²^ORCID,Yakushijin Takayuki²³,Kawamoto Seiichi²⁴

Affiliation:

1. Departments of Laboratory Medicine Osaka General Medical Center Osaka Japan

2. Liver Cancer Center Osaka General Medical Center Osaka Japan

3. Gastroenterology and Hepatology Osaka General Medical Center Osaka Japan

4. Diagnostic Imaging Osaka General Medical Center Osaka Japan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3674

Reference16 articles.

1. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

2. Sorafenib in Advanced Hepatocellular Carcinoma

3. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

4. Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo

5. c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database;Heliyon;2024-09

2. The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS;Bioanalysis;2024-08-14

3. Postbiotics as Adjuvant Therapy in Cancer Care;Nutrients;2024-07-24

4. Vitamin K2 in Health and Disease: A Clinical Perspective;Foods;2024-05-24

5. The Influence of Diet and Its Components on the Development and Prevention of Hepatocellular Carcinoma (HCC);Cancers;2024-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3